CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Budapest, Hungary and 210 other locations
to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...
Phase 3
Budapest, Hungary and 50 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Budapest, Hungary and 263 other locations
Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common fo ...
Phase 2
Budapest, Hungary and 40 other locations
This study is designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Budapest, Hungary and 233 other locations
combination with Atezolizumab compared to Standard-of-Care Therapy in adult participants with previously untreated extensive-stage small cell lung...
Phase 3
Budapest, Hungary and 61 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Törökbálint, Hungary and 95 other locations
The main objective is to compare the efficacy of tarlatamab with standard of care (SOC) on prolonging overall survival (OS).
Phase 3
Budapest, Hungary and 224 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Budapest, Hungary and 230 other locations
purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...
Phase 2
Tatabánya, Hungary and 73 other locations
Clinical trials
Research sites
Resources
Legal